https://www.selleckchem.com/pr....oducts/trc051384.htm
ned significantly associated with AAA growth after adjustment for other relevant clinical factors (coef -0.057; p0.0001). Patients with diabetes have more than a 35% reduction in the median growth rates of AAA despite more severe concomitant vascular co-morbidities and similar initial sizes of aneurysms. This effect persists and remains robust after adjusted analysis; and slower growth rates may delay the time to reach repair threshold. Rapid growth (0.5 cm/year) is infrequent in diabetic patients. 0.5 cm/year) is infrequent i